Acetylsalicylic acid (Aspirin, BAYE4465) + Paracetamol + Placebo
ApprovedCompleted 0 watching 0 views this week๐ฅ Hot
82
Development Stage
โ
Pre-clinicalโ
Phase 1โ
Phase 2โ
Phase 35
ApprovedIndication / Disease
Common Cold
Conditions
Common Cold, Pharyngitis, Tonsillitis
Trial Timeline
Nov 1, 2003 โ Mar 1, 2005
NCT ID
NCT01465009About Acetylsalicylic acid (Aspirin, BAYE4465) + Paracetamol + Placebo
Acetylsalicylic acid (Aspirin, BAYE4465) + Paracetamol + Placebo is a approved stage product being developed by Bayer for Common Cold. The current trial status is completed. This product is registered under clinical trial identifier NCT01465009. Target conditions include Common Cold, Pharyngitis, Tonsillitis.
Hype Score Breakdown
Clinical
30
Activity
20
Company
7
Novelty
10
Community
12
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT01465009 | Approved | Completed |
Competing Products
20 competing products in Common Cold